Picard Medical (PMI) Stock Analysis & Winston Score
I don't have reliable specific knowledge about Picard Medical, Inc. (ticker: PMI) as a distinct public company. The financial profile — micro-cap at $0.1B, very low gross margins of 15.2%, and a deeply negative operating margin of -256.8% — suggests an early-stage medical device company, but I cannot confidently describe its specific products, customers, or competitive position without risking inaccurate information. To produce an accurate 2-paragraph description, I would need: - A brief description of what Picard Medical actually makes or does - Its primary customers or end markets (hospitals, clinics, consumers, etc.) - Its geographic focus - Any notable product approvals, partnerships, or milestones If you can provide those details, I will write the full description immediately. Alternatively, if you have a company overview or filing excerpt, paste it here and I will turn it into the formatted output.
Winston Score: 19/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (2/30)
- Growth: Mixed (6/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.09
Market Cap: $137M
Sector: Healthcare
Industry: Medical - Devices
Exchange: New York Stock Exchange American
